390
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Reproductive Health Care Utilization by Women Who Inject Drugs and Exchange Sex in the Seattle Area

, ORCID Icon, &

References

  • Armstrong, G. (2017). Commentary on McFall et al. (2017): The need for harm reduction interventions that are effective for women who use drugs. Addiction (Abingdon, England), 112(8), 1488–1489. https://doi.org/10.1111/add.13856
  • Astemborski, J., Vlahov, D., Warren, D., Solomon, L., & Nelson, K. E. (1994). The trading of sex for drugs or money and HIV seropositivity among female intravenous drug users. American Journal of Public Health, 84(3), 382–387. https://doi.org/10.2105/ajph.84.3.382
  • Bellanca, H. K., & Hunter, M. S. (2013). ONE KEY QUESTION®: Preventive reproductive health is part of high quality primary care. Contraception, 88(1), 3–6. https://doi.org/10.1016/j.contraception.2013.04.074
  • Black, K. I., Stephens, C., Haber, P. S., & Lintzeris, N. (2012). Unplanned pregnancy and contraceptive use in women attending drug treatment services. The Australian & New Zealand Journal of Obstetrics & Gynaecology, 52(2), 146–150. https://doi.org/10.1111/j.1479-828X.2012.01413.x
  • Chacham, A. S., Diniz, S. G., Maia, M. B., Galati, A. F., & Mirim, L. A. (2007). Sexual and reproductive health needs of sex workers: Two feminist projects in Brazil. Reproductive Health Matters, 15(29), 108–118. https://doi.org/10.1016/S0968-8080(07)29292-4
  • Des Jarlais, D. C., McKnight, C., Goldblatt, C., & Purchase, D. (2009). Doing harm reduction better: Syringe exchange in the United States. Addiction, 104(9), 1441–1446. https://doi.org/10.1111/j.1360-0443.2008.02465.x
  • Finer, L. B., & Zolna, M. R. (2016). Declines in unintended pregnancy in the United States, 2008-2011. The New England Journal of Medicine, 374(9), 843–852. https://doi.org/10.1056/NEJMsa1506575
  • Golden, M. R., Lechtenberg, R., Glick, S. N., Dombrowski, J., Duchin, J., Reuer, J. R., Dhanireddy, S., Neme, S., & Buskin, S. E. (2019). Outbreak of human immunodeficiency virus infection among heterosexual persons who are living homeless and inject drugs - Seattle, Washington, 2018. MMWR. Morbidity and Mortality Weekly Report, 68(15), 344–349. https://doi.org/10.15585/mmwr.mm6815a2
  • Heil, S. H., Jones, H. E., Arria, A., Kaltenbach, K., Coyle, M., Fischer, G., Stine, S., Selby, P., & Martin, P. R. (2011). Unintended pregnancy in opioid-abusing women. Journal of Substance Abuse Treatment, 40(2), 199–202.
  • Islam, M. M., Topp, L., Day, C. A., Dawson, A., & Conigrave, K. M. (2012). The accessibility, acceptability, health impact and cost implications of primary healthcare outlets that target injecting drug users: A narrative synthesis of literature. The International Journal on Drug Policy, 23(2), 94–102.
  • Kavanaugh, M. L., & Jerman, J. (2018). Contraceptive method use in the United States: Trends and characteristics between 2008, 2012 and 2014. Contraception, 97(1), 14–21.
  • MacAfee, L. K., Harfmann, R. F., Cannon, L. M., Kolenic, G., Kusunoki, Y., Terplan, M., & Dalton, V. K. (2020). Sexual and reproductive health characteristics of women in substance use treatment in Michigan. Obstetrics and Gynecology, 135(2), 361–369. https://doi.org/10.1097/AOG.0000000000003666
  • MacAfee, L. K., Harfmann, R. F., Cannon, L. M., Minadeo, L., Kolenic, G., Kusunoki, Y., & Dalton, V. K. (2020). Substance use treatment patient and provider perspectives on accessing sexual and reproductive health services: Barriers, facilitators, and the need for integration of care. Substance Use & Misuse, 55(1), 95–107.
  • Nerlander, L. M., Hess, K. L., Rose, C. E., Sionean, C., Thorson, A., Broz, D., & Paz-Bailey, G. (2017). NHBS study group. Exchange sex and HIV infection among women who inject drugs. Journal of Acquired Immune Deficiency Syndromes, 75(Suppl 3), S333–S340.
  • Pazol, K., Robbins, C. L., Black, L. I., Ahrens, K. A., Daniels, K., Chandra, A., Vahratian, A., & Gavin, L. E. (2017). Receipt of selected preventive health services for women and men of reproductive age - United States, 2011-2013. Morbidity and Mortality Weekly Report. Surveillance Summaries (Washington, DC.: 2002), 66(20), 1–31.
  • Pinkham, S., & Malinowska-Sempruch, K. (2008). Women, harm reduction and HIV. Reproductive Health Matters, 16(31), 168–181.
  • Rey, C. N., Badger, G. J., Melbostad, H. S., Wachtel, D., Sigmon, S. C., MacAfee, L. K., Dougherty, A. K., & Heil, S. H. (2020). Perceptions of long-acting reversible contraception among women reeciving medication for opioid use disorder in Vermont. Contraception, 101(5), 333–337. https://doi.org/10.1016/j.contraception.2020.01.010
  • Terplan, M., Lawental, M., Connah, M. B., & Martin, C. E. (2016). Reproductive health needs among substance use disorder treatment clients. Journal of Addiction Medicine, 10(1), 20–25. https://doi.org/10.1097/ADM.0000000000000175
  • Treloar, C., Rance, J., Yates, K., & Mao, L. (2016). Trust and people who inject drugs: The perspectives of clients and staff of Needle Syringe Programs. The International Journal on Drug Policy, 27, 138–145. https://doi.org/10.1016/j.drugpo.2015.08.018
  • Trussell, J., Aiken, A. R. A., Micks, E., & Guthrie, K. A. (2018). Efficacy, safety, and personal considerations. In R. A. Hatcher, A. L. Nelson, J. Trussell, C. Cwiak, P. Cason, M. S. Policar, A. Edelman, A. R. A. Aiken, J. Marrazzo, & D. Kowal (Eds.), Contraceptive technology (21st ed.). Ayer Company Publishers, Inc.
  • Wellings, K., Jones, K. G., Mercer, C. H., Tanton, C., Clifton, S., Datta, J., Copas, A. J., Erens, B., Gibson, L. J., Macdowall, W., Sonnenberg, P., Phelps, A., & Johnson, A. M. (2013). The prevalence of unplanned pregnancy and associated factors in Britain: Findings from the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3). Lancet (London, England)), 382(9907), 1807–1816. https://doi.org/10.1016/S0140-6736(13)62071-1
  • Young, M., Stuber, J., Ahern, J., & Galea, S. (2005). Interpersonal discrimination and the health of illicit drug users. The American Journal of Drug and Alcohol Abuse, 31(3), 371–391. https://doi.org/10.1081/ADA-200056772

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.